[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368496-105":59,"doc-detail-368496-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","deciphering-the-multifaceted-role-of-exo1-in-female-related-cancers-implications-for-prognosis-and-therapeutic-responsiveness","Deciphering the multifaceted role of EXO1 in female-related cancers - implications for prognosis and therapeutic responsiveness","","This study examines how aberrant exonuclease 1 (EXO1) function or overactivation relates to cancer development, drug resistance, and immunotherapy response in female-related cancers. RNA-sequencing data from The Cancer Genome Atlas are integrated with quantitative polymerase chain reaction validation across breast cancer cell lines. Elevated EXO1 expression aligns with RNA-seq results and is linked to poorer prognosis in multiple cancers, while expression associates with immune microenvironment features and potential anticancer drug sensitivity.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/deciphering-the-multifaceted-role-of-exo1-in-female-related-cancers-implications-for-prognosis-and-therapeutic-responsiveness/368496/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/deciphering-the-multifaceted-role-of-exo1-in-female-related-cancers-implications-for-prognosis-and-therapeutic-responsiveness/368496.png","ImageObject",300,407,{"name":92,"@type":93},"Aria Callaghan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-09","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does the study investigate about EXO1 in female-related cancers?","Question",{"text":112,"@type":113},"The study investigates how EXO1 expression and function relate to cancer progression, drug resistance, prognosis, and responsiveness to immunotherapy in female-related cancers.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were EXO1 expression patterns analyzed?",{"text":117,"@type":113},"Expression levels were assessed using RNA-sequencing data from The Cancer Genome Atlas, and validated through quantitative polymerase chain reaction experiments in breast cancer cell lines.",{"name":119,"@type":110,"acceptedAnswer":120},"What does the study conclude about the role of EXO1?",{"text":121,"@type":113},"EXO1 shows multidimensional roles as a prognostic biomarker and may influence tumor immune therapy responses and drug sensitivities, though further mechanistic studies are needed.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368496,1790362839,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962084926284,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","TYPE Original Research PUBLISHED 12 May 2025  \nDOI 10.3389/fimmu.2025.1591505  \nOPEN ACCESS  \nEDITED BY  \nSubhadip Das,  \nTCG Lifesciences, India  \nREVIEWED BY  \nVaibhavi V. Gujar,  \nNational Institutes of Health (NIH), United States  \nPaula Dobosz,  \nPoznan University of Medical Sciences, Poland  \nTianyu Wang,  \nTongji University, China  \n*CORRESPONDENCE  \nGuoying Wu  \n [guoying.wu@qlnu.edu.cn](guoying.wu@qlnu.edu.cn)  \nRECEIVED 11 March 2025  \nACCEPTED 21 April 2025  \nPUBLISHED 12 May 2025  \nCITATION  \nYu C and Wu G (2025) Deciphering the multifaceted role of EXO1 in female-related cancers: implications for prognosis and therapeutic responsiveness.  \nFront. Immunol. 16:1591505 .  \ndoi: 10.3389/fimmu.2025.1591505  \nCOPYRIGHT  \n© 2025 Yu and Wu. This is an open-access article distributed under the terms of the  \nCreative Commons Attribution License (CC BY) .  \nThe use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nDeciphering the multifaceted role of EXO1 in female-related cancers: implications for prognosis and therapeutic responsiveness  \nCong Yu and Guoying Wu*  \nSchool of Life Sciences, Qilu Normal University, Jinan, China  \nBackground: Aberrant function or overactivation of exonuclease 1 (EXO1) maybe associated with cancer tumor development, drug resistance, and response to immunotherapy in female-related cancers.  \nMethods: By analyzing RNA-sequencing data from The Cancer Genome Atlas database, combined with validation through quantitative polymerase chain reaction experiments, we explored the expression levels of EXO1 in breast cancer (BRCA) cell lines and assessed its multidimensional roles in various female-related cancers.  \nResults: Our experiments revealed elevated expression of EXO1 in BRCA cell lines, consistent with the RNA-sequencing data. The high expression of EXO1 is associated with poor prognosis in various female-related cancers, especially in BRCA and UCEC. It signiﬁcantly correlates with clinical and pathological characteristics. In speciﬁc cancer subtypes like the basal-like subtype of BRCA, high EXO1 expression is associated with a better prognosis. Genetic mutation analysis indicates a higher frequency of EXO1 gene mutations in uterine sarcoma and BRCA. DNA methylation levels may play a role in the regulation of EXO1 gene expression in some cancers. EXO1 expression is correlated with various factors within the tumor immune microenvironment and may be associated with the sensitivity to anticancer drugs.  \nConclusion: EXO1 exhibits multidimensional roles in female-related cancers as a prognostic biomarker and potentially inﬂuences tumor immune therapy responses and drug sensitivities. Further studies are needed to fully understand the complex mechanisms underlying these associations and to explore potential therapeutic strategies targeting EXO1 .  \nKEYWORDS  \nEXO1, female-related cancers, prognostic biomarkers, tumor immune microenvironment, drug sensitivity prediction  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \n1 Introduction  \nIn recent years, there has been a continuous increase in the number of patients with cancer globally. By 2020, the number of patients with cancer worldwide had reached 19.3 million, with 9.228 million being women, representing 47.8% of the total patient population (1) . The most prevalent types of cancer in women are breast cancer (BRCA), cervical cancer (CESC), uterine corpus endometrial cancer (UCEC), ovarian cancer (OV), thyroid cancer (THCA), uterine sarcoma (UCS), etc. These cancers account for 44.5% of all female-related cancer cases and have a mortality rate of 31.3%(1) . BRCA ranks among the most prevalent malignancies in women. In 2024, it was projected that there would","cbCaiqgP4ikcRNKh","https://ap.wps.com/l/cbCaiqgP4ikcRNKh","pdf",9692466,22,"English","# Introduction\n## EXO1 and DNA repair background\n# Methods\n# Results\n# Conclusion","[{\"question\":\"What question does the study investigate about EXO1 in female-related cancers?\",\"answer\":\"The study investigates how EXO1 expression and function relate to cancer progression, drug resistance, prognosis, and responsiveness to immunotherapy in female-related cancers.\"},{\"question\":\"How were EXO1 expression patterns analyzed?\",\"answer\":\"Expression levels were assessed using RNA-sequencing data from The Cancer Genome Atlas, and validated through quantitative polymerase chain reaction experiments in breast cancer cell lines.\"},{\"question\":\"What does the study conclude about the role of EXO1?\",\"answer\":\"EXO1 shows multidimensional roles as a prognostic biomarker and may influence tumor immune therapy responses and drug sensitivities, though further mechanistic studies are needed.\"}]","Deciphering the multifaceted role of EXO1 in female-related cancers - implications for prognosis and therapeutic responsiveness | PDF",1790177244,55,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4f6c685f5ed02a5c988c24598d3df915.webp",983,1389,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7bf9ed196e24855fcb6e2801e894b7a6.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3262cbf68b215659b1530a059dac8f03.webp",981,1386,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd297d3ab0d43e4b37a51ed52e1f2596.webp",980,1385]